LAVA Therapeutics (LVTX)
(Delayed Data from NSDQ)
$1.63 USD
-0.05 (-2.98%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $1.67 +0.04 (2.45%) 7:58 PM ET
4-Sell of 5 4
D Value F Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/21/2024
Time: -- |
9/2024 | $-0.35 | 0.00% |
Earnings Summary
For their last quarter, LAVA Therapeutics (LVTX) reported earnings of -$0.31 per share, beating the Zacks Consensus Estimate of $-0.33 per share. This reflects a positive earnings surprise of 6.06%. Look out for LVTX's next earnings release expected on November 21, 2024. For the next earning release, we expect the company to report earnings of -$0.35 per share, reflecting a year-over-year decrease of 2.94%.
Earnings History
Price & Consensus
Zacks News for LVTX
Eton Pharmaceuticals, Inc. (ETON) Reports Q4 Loss, Lags Revenue Estimates
LVTX: What are Zacks experts saying now?
Zacks Private Portfolio Services